SEMAGLUTIDE 1 mg/0.5 mL (Noveltreat) Injectable Solution

SEMAGLUTIDE 1 mg/0.5 mL (Noveltreat) Injectable Solution

$160.00 $85.00
Prescription Required

SEMAGLUTIDE 1 mg/0.5 mL (Noveltreat) Injectable Solution is a prescription once-weekly GLP-1 receptor agonist used to improve blood sugar control in adults with type 2 diabetes. It may also help reduce appetite, support weight management, and lower the risk of certain cardiovascular events in eligible patients when used alongside a healthy diet and regular exercise.

Generic name SEMAGLUTIDE
Strength 1 mg
Manufacturer Sun Pharmaceutical
Package size 2 Single Dose Prefilled Pens of 1 mg/0.5 ml
Used for Type 2 diabetes and chronic weight management
Availability In Stock
Shipping to USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, UAE, Georgia, Armenia, Saudi Arabia, Qatar, Kuwait, South Africa, and many other countries.
Enquire via WhatsApp

Uses of SEMAGLUTIDE 1 mg

  • Improves blood sugar control in adults with type 2 diabetes
  • Supports long-term glucose management
  • Helps with weight management when prescribed
  • Helps reduce appetite and food intake
  • May lower the risk of major cardiovascular events in eligible patients

Benefits of SEMAGLUTIDE

  • Helps lower HbA1c levels
  • May support significant weight loss in suitable patients
  • Provides convenient once-weekly dosing
  • Helps reduce hunger and food cravings
  • May support overall metabolic health

How Does SEMAGLUTIDE 1 mg Work?

Semaglutide 1 mg works by mimicking the action of glucagon-like peptide-1 (GLP-1), a natural hormone that increases insulin release when blood sugar levels are high. It also reduces glucagon secretion, slows stomach emptying, and decreases appetite. These combined effects help improve blood sugar control and support weight management.

Side Effects

  • Nausea
  • Vomiting
  • Diarrhoea
  • Constipation
  • Decreased appetite
  • Stomach pain
  • Indigestion
  • Injection-site reactions

Precautions

  • Use only under the supervision of a healthcare provider.
  • It is not recommended for people with type 1 diabetes.
  • Inform your doctor if you have a history of pancreatitis, kidney disease, gallbladder disease, or diabetic retinopathy.
  • Monitor your blood sugar regularly, especially when using semaglutide with insulin or sulfonylureas.
  • Tell your healthcare provider if you are pregnant, planning a pregnancy, or breastfeeding.
  • Follow the prescribed once-weekly dosing schedule and do not exceed the recommended dose.
Enquire via WhatsApp